Glycemic Variability: Assessing Glycemia Differently and the Implications for Dietary Management of Diabetes
Open accessThe DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Abstract
The primary therapeutic target for diabetes management is the achievement of good glycemic control, of which glycated hemoglobin (HbA1c) remains the standard clinical marker. However, glycemic variability (GV; the amplitude, frequency, and duration of glycemic fluctuations around mean blood glucose) is an emerging target for blood glucose control. A growing body of evidence supports GV as an independent risk factor for diabetes complications. Several techniques have been developed to assess and quantify intraday and interday GV. Additionally, GV can be influenced by several nutritional factors, including carbohydrate quality, quantity; and distribution; protein intake; and fiber intake. These factors have important implications for clinical nutrition practice and for optimizing blood glucose control for diabetes management. This review discusses the available evidence for GV as a marker of glycemic control and risk factor for diabetes complications. GV quantification techniques and the influence of nutritional considerations for diabetes management are also discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intensive versus Conventional Glucose Control in Critically Ill Patients
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810625 · Cited by 5,119 · cited 1×
“Recent evidence suggests GV (assessed predominantly by SD), particularly if accompanied by frequent hypoglycemic episodes, may adversely affect the prognosis of critically ill patients (52, 73, 130, 169, 232).”
BackgroundGlucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762 · cited 4×
“Strict glucose control (HbA1c < 6%) achieved by intensive therapy in the ADVANCE, ACCORD, and VADT studies was associated with increased risk of hypoglycemia (1, 2, 72).”
BackgroundMethodInfluentialStandards of medical care in diabetes—2013
American Diabetes Association (2013) · Diabetes Care · doi:10.2337/dc13-s011 · Cited by 4,369
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2012) · Diabetologia · doi:10.1007/s00125-012-2534-0 · Cited by 3,919
Glycemic index of foods: a physiological basis for carbohydrate exchange
Jenkins, D. J., Wolever, T. M., Taylor, R. H., Barker, H., Fielden, H., Baldwin, J. M., Bowling, A. C., Newman, H. C., Jenkins, A. L., & Goff, D. V. (1981) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/34.3.362 · Cited by 3,857 · cited 1×
“The GI ranks foods on the basis of the incremental blood glucose responses they produce for a given amount of carbohydrate compared with an equivalent quantity of carbohydrate in glucose or white bread (115).”
BackgroundInternational Expert Committee report on the role of the A1c assay in the diagnosis of diabetes
The International Expert Committee (2009) · Diabetes Care · doi:10.2337/dc09-9033 · Cited by 3,185
Diagnosis and classification of diabetes mellitus
American Diabetes Association (2013) · Diabetes Care · doi:10.2337/dc13-s067 · Cited by 2,245
Esposito, K., Nappo, F., Marfella, R., Giugliano, G., Giugliano, F., Ciotola, M., Quagliaro, L., Ceriello, A., & Giugliano, D. (2002) · Circulation · doi:10.1161/01.cir.0000034509.14906.ae · Cited by 1,961 · cited 1×
“Pathophysiological studies describing the process by which glucose oscillations potentiate the harmful effects of stable hyperglycemia on endothelial cells, inflammatory cytokines, and free radical detoxification support this notion (77, 107, 178, 182); glucose oscillations are possibly mediated by the “metabolic memo…”
BackgroundMeta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus
Selvin, E., Marinopoulos, S., Berkenblit, G., Rami, T., Brancati, F. L., Powe, N. R., & Golden, S. H. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-6-200409210-00007 · Cited by 1,657
Chiasson, J.-L., Josse, R. G., Gomis, R., Hanefeld, M., Karasik, A., Laakso, M., & for The STOP-NIDDM Trial Research Group (2003) · JAMA · doi:10.1001/jama.290.4.486 · Cited by 1,624 · cited 1×
“Similarly, oral hypoglycemic agents (OHGAs), including α-glucosidase inhibitors (8, 45, 57, 99), glucagon-like peptide 1 (GLP-1) derivatives (8), dipeptidyl peptidase- 4 (DPP-4) inhibitors (9, 13), glinides (76, 100, 189, 239), and short-acting sulfonylureas (39), that target PPG reduce”
Background
Cited by
Comparison of low- and high-carbohydrate diets for type 2 diabetes management: a randomized trial
Tay, J., Luscombe-Marsh, N. D., Thompson, C. H., Noakes, M., Buckley, J. D., Wittert, G. A., Yancy, W. S., & Brinkworth, G. D. (2015) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.115.112581 · Cited by 341
“Previous studies have also limited the assessment of glycemic control to glycated hemoglobin (HbA1c) (6–11); frequently without an objective quantification of diabetes medication changes or the assessment of glycemic variability (GV), which is an emerging independent risk factor for diabetes-related complications (12,…”
BackgroundSelf-citationTay, J., Thompson, C. H., Luscombe‐Marsh, N. D., Wycherley, T. P., Noakes, M., Buckley, J. D., Wittert, G. A., Yancy, W. S., & Brinkworth, G. D. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13164 · Cited by 215
Self-citationKenđel Jovanović, G., Mrakovcic-Sutic, I., Pavičić Žeželj, S., Šuša, B., Rahelić, D., & Klobučar Majanović, S. (2020) · Nutrients · doi:10.3390/nu12113583 · Cited by 73
“Although HbA1c remains the standard clinical marker of glycemic control, glycemic variability (GV) is an emerging target for blood glucose control and an independent risk factor for diabetes complications [67].”
Mihai, B. M., Mihai, C., Cijevschi-Prelipcean, C., Grigorescu, E.-D., Dranga, M., Drug, V., Sporea, I., & Lăcătușu, C. M. (2018) · Journal of Diabetes Research · doi:10.1155/2018/1736959 · Cited by 46
“Besides the stimulation of insulin secretion (driven by direct stimulatory effects, but also indirectly, through an increased incretin response), underlying pathways include delayed gastric emptying under the influence of the same incretin hormones [62].”
BackgroundFirst-phase insulin secretion: can its evaluation direct therapeutic approaches?
Di Giuseppe, G., Ciccarelli, G., Soldovieri, L., Capece, U., Cefalo, C. M. A., Moffa, S., Nista, E. C., Brunetti, M., Cinti, F., Gasbarrini, A., et al. (2023) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2023.02.001 · Cited by 46
Metadata
- Authors
- Tay, J., Thompson, C. H., & Brinkworth, G. D.
- Venue
- Annual Review of Nutrition
- Publisher
- Annual Reviews
- Published
- 2015-07-17
- Volume
- 35
- Issue
- 1
- Pages
- 389-424
- ISSN
- 0199-9885 (ISSN-L)
- 1545-4312
- OpenAlex
- W2132751068
- Cited by
- 61
- References
- 70
- FWCI
- 0.88
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Glycemic Variability: Assessing Glycemia Differently and the Implications for Dietary Management of Diabetes. https://app.cochat.ai/papers/10.1146/annurev-nutr-121214-104422
- The paper
- Tay, J., Thompson, C. H., & Brinkworth, G. D. (2015). Glycemic Variability: Assessing Glycemia Differently and the Implications for Dietary Management of Diabetes. Annual Review of Nutrition. https://doi.org/10.1146/annurev-nutr-121214-104422
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.